Kiora Pharmaceuticals @KioraPharma
(NASDAQ: KPRX) Clinical development-stage pharmaceutical company focusing on novel therapeutics for treatment of orphan retinal diseases with high unmet need. kiorapharma.com Encinitas, CA Joined August 2017-
Tweets286
-
Followers1K
-
Following787
-
Likes91
$KPRX Our EVP of Finance, Melissa Tosca, discussed our pipeline, partnerships, and milestones at last week's Noble Emerging Growth Conference. If you missed the live presentation, you can now view the replay from our IR homepage - ir.kiorapharma.com
There's a wonderful network of caregivers, doctors, nurses, families, and advocates supporting greater independence to people who are blind or visually impaired. Today we want to recognize the incredible life of Trigger who fathered 300+ guide dogs. bbc.com/news/uk-englan…
$KPRX We invite you to view today's investor presentation. CEO Dr. Strem: "Approvable endpoints (KIO-301) will be based on functional measures…We received a grant from CRF (today) to help develop these…then leverage in the upcoming Phase 2 study." wsw.com/webcast/needha…
$KPRX We're partnering with @curechm and @oraclinical on important work related to bringing about new treatments for inherited retinal diseases. The goal is to enhance and validate trial endpoints that correlate to improvements in everyday life. ir.kiorapharma.com/news-events/pr…
$KPRX We invite you to view our upcoming investor presentations. We'll be presenting at the Needham Healthcare Conference on April 11th at 10:15 am EDT and the Noble Capital Markets Emerging Growth Healthcare Conference on April 18th at 2:30 pm EDT.
What do autoimmune diseases, like #rheumatoidarthritis, have to do with eye diseases such as #uveitis? Surprisingly (nor not surprisingly), a lot. We wanted to share this informative read on the role these conditions can have on vision...healthcentral.com/condition/rheu…
$KPRX We look forward to presenting additional data from our ABACUS-1 study in retinitis pigmentosa, which has been accepted for presentation at ARVO 2024 in early May. The additional data includes quantitative evaluation of the functional MRI measures. ir.kiorapharma.com/news-events/pr…
When it comes to KIO-104, a great question we often encounter is, what exactly is #uveitis? This video offers a succinct explanation of the condition and its risk to vision if left untreated. webmd.com/eye-health/vid…
$KPRX YE results are out. Productive '23 and start to '24. Key highlights: Clinical proof-of-concept in 2 rare retinal diseases- inherited (KIO-301) & inflammatory (KIO-104); Pharma partner for KIO-301; $30+MM cash, which we expect funds ops through 2026 bit.ly/4cwgwRH
A favorite study of ours on American attitudes toward vision loss gets to the heart of our mission. It confirmed eye health research is a priority and reaffirmed the need to educate the public and mobilize support for vision research Have a read... jamanetwork.com/journals/jamao…
$KPRX Our KIO-101 Ph 1 study results were published this week; Data showed safety, tolerability and anti-inflammatory activity of the KIO-100 family of compounds in the treatment of inflammation of the eye. ir.kiorapharma.com/news-events/pr…
🚨 IT'S RARE DISEASE DAY GLOBALLY! 🚨 Join us marking #RareDiseaseDay 2024! Spread awareness, share stories, and support those living with rare diseases. Together, we make a lasting impact! #ShareYourColours
Today we celebrate the patients, families, advocacy groups, and members of the medical community who are working together to create awareness of and treatments for rare disease. #rarediseaseday #retinitispigmentosa #Choroideremia #Stargardt
Meet the companies presenting their latest innovations at next week's Global Life Science Partnering & Investor Conference. Learn more: bit.ly/3SUtEIw #BiocomGPIC
$KPRX We're pleased to announce our partnership with Théa Open Innovation to develop KIO-301 for treatment of inherited retinal diseases. This is a major step toward bringing a potential-new treatment for patients with an IRD such as retinitis pigmentosa > bit.ly/3SFWKeH
Topline observations reported at #AAO23 indicated that KIO-301is safe and well tolerated. #Retinitispigmentosa #RP#Stargardts #Choroideremia #sightloss #RetinalDystrophy $KPRX buff.ly/47BuAH0
$KPRX's Brian Strem and Jack O’Brien talk KIO-301. "These patients have nothing available...If our drug, or any drug, is able to provide clinically-meaningful improvements in day to day living, that is something we think will get across the finish line and will get covered.”
$KPRX's Brian Strem and Jack O’Brien talk KIO-301. "These patients have nothing available...If our drug, or any drug, is able to provide clinically-meaningful improvements in day to day living, that is something we think will get across the finish line and will get covered.”
Kiora Pharmaceuticals Recently Released Clinical Data Demonstrating Proof-of-Concept. #RetinitisPigmentosa #RP #blindness #data #rareinherited #AAO2023 $KPRX buff.ly/47BuAH0
$KPRX Fresh off of reporting results from our Ph I/II study in Retinitis Pigmentosa, our CEO Dr. Strem talks next steps for KIO-301 across multiple inherited retinal diseases. youtube.com/watch?v=ZwXMEV…
Foundation Fighting B.. @FightBlindness
15K Followers 3K Following We are the driving force in the global development of treatments and cures for blinding diseases.
HODOR @Maximus_Holla
44K Followers 1K Following Swing & day trader Tweets are my opinion only and not a recommendation to buy or sell any security. Parody account!
Insider Financial @InsidrFinancial
32K Followers 10K Following The team at Insider Financial covers the hottest small cap stocks. Not financial advice and not investment advisers. Read the full disclaimer before signing up!
Totoyez @totoyez66855
0 Followers 167 Following
Teatea @Teateaqdn
0 Followers 89 Following
ElaineSaxton @8zi677nS5012u9
0 Followers 126 Following
Shestun @ShestunMJLdp
0 Followers 123 Following
Marwan Alhamdi @marwanalhamdi
148 Followers 636 Following
Tirsmau @tirsmau17566
0 Followers 107 Following
Theytorn @TheytornXZm_
0 Followers 128 Following
Shirree @Shirree832535
30 Followers 258 Following
kmorejuicy @juicyk99
78 Followers 72 Following here for the updates. too cheap to buy a blue arrow 🙂
melon@ @vanclimber1
90 Followers 429 Following
Geathay @Geathay17062
177 Followers 5K Following
By X @Bye_x_hey
4 Followers 255 Following
Edward Carter, Jr. @carter_jr2
95 Followers 275 Following
Hannah Bynam @bynam_by
62 Followers 5K Following
Mira Mcpeek @McpeekMi
78 Followers 5K Following
Jessica Nakamura @RxPhoenix86
1 Followers 5 Following
Carie Braga @BragaCarie70195
33 Followers 5K Following
Recite Me Australia @ReciteMe_AUS
14 Followers 40 Following Accessibility + Usability = Inclusion. Recite Me bridges the gap between accessibility and usability, creating inclusive experiences online for everyone.
Gashaez @gashaez33580
48 Followers 2K Following
National Alliance for.. @NAEVRAdvocacy
642 Followers 2K Following The National Alliance for Eye & Vision Research serves as Friends of the National Eye Institute with members representing professionals, consumers, and industry
Piet Pijpelink @PietPijpelink
15 Followers 707 Following
Laura Valentin @LauraVa48000861
134 Followers 3K Following Connect with our Surgeons at Orthopedic 2024 in Bangkok, Thailand #orthopedics #orthopedic #orthopaedics #rheumatology #orthopedicsurgery #orthopedicsurgeon
Moon Market @MoonMarket_
79K Followers 342 Following YouTube/MoonMarket 100k Subs. I tweet stocks im day trading or thinking about trading. I don't hold penny stocks long term. https://t.co/LRFBL31SZo
Antonio Costa @ACInvestorBlog
176K Followers 498 Following I'm a 50 year old private trader using proprietary technical analysis w/+20yrs experience of investing in stock markets. Do your own research. Tweets not advice
Pharmdca @Pharmdca
90K Followers 141 Following USC Pharmacy Alumni, Full Time Investor. My tweets are a general reflection of where Iam investing money and not a recommendation. Please do your due diligence.
Foundation Fighting B.. @FightBlindness
15K Followers 3K Following We are the driving force in the global development of treatments and cures for blinding diseases.
BioEternalDamnation P.. @pawcio2009
13K Followers 701 Following Biosquidgames organizer. I jinx for living. 🇵🇱🇨🇦⚽️📈🎣🚴♂
Ocugen @Ocugen
50K Followers 210 Following Approaching healthcare innovation with ingenuity, passion and courage to create new solutions to difficult medical challenges. Guidelines: https://t.co/SYzUIr1zPD
Bio Stocks™ @BioStocks
65K Followers 84 Following Investor/trader focused primarily in the biopharma sector. Tweets are not investment advice and are not recommendations of any kind.
HODOR @Maximus_Holla
44K Followers 1K Following Swing & day trader Tweets are my opinion only and not a recommendation to buy or sell any security. Parody account!
ARVO @ARVOinfo
24K Followers 588 Following The Association for Research in Vision and Ophthalmology has more than 11,000 members worldwide
Insider Financial @InsidrFinancial
32K Followers 10K Following The team at Insider Financial covers the hottest small cap stocks. Not financial advice and not investment advisers. Read the full disclaimer before signing up!
dough @semodough
37K Followers 569 Following BIOTECH man LONGTERM FOCUS many positions-also trade around my CORE holdings my opinion only do your own research with me
Matt Hirabayashi, MD @EyeFlyMD
6K Followers 201 Following @MizzouOphtho chief resident | Refractive, research, innovation, & education | Sharing ophthalmology as I understand it | Education, not advice |
AAO @aao_ophth
42K Followers 274 Following The American Academy of Ophthalmology is the world’s largest association of eye physicians and surgeons.
National Alliance for.. @NAEVRAdvocacy
642 Followers 2K Following The National Alliance for Eye & Vision Research serves as Friends of the National Eye Institute with members representing professionals, consumers, and industry
UserWay @UserWayOrg
725 Followers 345 Following The accessible web runs on UserWay 🚀 Trusted by 1M+ websites 💻
GSNV @gsnv_info
745 Followers 2K Following The GSNV is an active organisation committed to promoting the interests and well-being of people affected by genetic, undiagnosed and rare conditions.
Blind Citizens Austra.. @au_BCA
2K Followers 2K Following Blind Citizens Australia (BCA) is the united voice of Australians who are blind or vision impaired. https://t.co/EHTW96LQrF https://t.co/9xTJplMaR5
Macular Society @MacularSociety
14K Followers 4K Following Beating the fear and isolation of macular disease with world-class research, and the best advice and support. 0300 3030 111. #BeatMacularDisease
accessiBe @AccessiBe
2K Followers 151 Following accessiBe is the leading web accessibility provider. Join us in our mission to open the Internet to everyone!
Recite Me Australia @ReciteMe_AUS
14 Followers 40 Following Accessibility + Usability = Inclusion. Recite Me bridges the gap between accessibility and usability, creating inclusive experiences online for everyone.
Recite Me US @ReciteMe_US
163 Followers 388 Following Accessibility + Usability = Inclusion. Recite Me bridges the gap between accessibility and usability, creating inclusive experiences online for everyone.
reciteme @reciteme
3K Followers 3K Following Accessibility + Usability = Inclusion. Recite Me bridges the gap between accessibility and usability, creating inclusive experiences online for everyone.
RareDiseaseFdn @rarediseasefdn
9K Followers 517 Following Changing the lives of patients affected by rare & undiagnosed diseases through social support, advocacy & treatment-focused research. https://t.co/qWTTVoKeyL
Rare Disease Report @RareDR
16K Followers 1K Following Breaking news, patient stories & FDA updates within the rare disease community. Listen to our podcast: https://t.co/xUkFDfCDUV, hosted by @GiulianaGrossi
Rare Disease UK @rarediseaseuk
22K Followers 2K Following National campaign run by @GeneticAll_UK to improve the lives of those affected by rare conditions and all who support them. #RareDisease.
Recordati Rare Diseas.. @RecordatiD
598 Followers 110 Following At Recordati Rare Diseases, we focus on the few - those affected by rare diseases. Social media guidelines: https://t.co/PEjh3QzOIW
Cure Rare Disease @CureRareDisease
4K Followers 256 Following 501(c)(3) nonprofit leading a nationwide collaboration of researchers and clinicians in order to develop life-saving therapeutics for rare diseases.
EURORDIS-Rare Disease.. @eurordis
32K Followers 2K Following An alliance of over 1,000 patient organisations working across borders and diseases to improve the lives of all people living with rare diseases.
Rare Diseases @CheckOrphan
18K Followers 5K Following CheckOrphan is the leading #news and information platform dedicated to #rarediseases and #orphandrugs
NORD @RareDiseases
41K Followers 3K Following National Organization for Rare Disorders (#NORD) is the voice of the #RareDisease community. Official US sponsor of #RareDiseaseDay.
Biocom California @BiocomCA
8K Followers 2K Following We are California’s leading advocate for life sciences.
GemSharpeEye👁️ @GemSharpex100
631 Followers 2K Following Early investor in #BTC with a sharp eye for hidden gems.. On a Mission🚀💎🌐
Cathleen McCabe, MD @CathyEye
2K Followers 2K Following Refractive cataract surgeon, experienced board member, innovator, researcher, educator, organization leader, speaker, advisor, investor, humanitarian, mom, Gmom
Eden Yoon, MD @EdenYoon
199 Followers 310 Following Double-Board Certified Eye Surgeon and Lifestyle Medicine, Husband, Father, Real Estate Investor, and international volunteer/traveler
𝕲𝖔𝖗𝖎𝖑�.. @GorillaTrading
6K Followers 84 Following Identifying Stocks With Catalysts, For Day/Swing/Long Trading. Setups Such As Technical Patterns/Catalyst News. Your Own DD ✍️ Is Still Imperative.
Simplesmente Edu 🇧.. @eddiedipiero
669 Followers 547 Following Médico formado na UFRJ, Velejador, Flamenguista, Carioca da Gema, anti-esquerdismo. Fã #1 do Whitesnake.
Enjooyer @0xEnjooyer
84K Followers 11K Following Crypto enjooyer since 2013 🚀 | Degen | Crypto, memecoin and NFT investoor | not a financial advisooor
Rachel Brooke MS 🧠.. @RachelBrookeMS
5K Followers 2K Following Market enthusiast-AI driven strategies. The future of trading with AI technology. Join the AI Trading revolution for smarter decisions and greater profits.
Walter Bogo @walterbogo
246 Followers 1K Following
RD Fund @RD_Fund
153 Followers 188 Following RD Fund focuses on mission-related investments to rapidly drive research into preventions, treatments and cures for blinding retinal diseases.
Eye Journal @Eye_Journal
4K Followers 164 Following Advancing the science and practice of ophthalmology with the latest clinical and scientific based research and studies
ASOA @ASOAtweets
9K Followers 1K Following The highest standard in ophthalmic practice management is the American Society of Ophthalmic Administrators (ASOA). AE Magazine, Meetings, COE, Education
IOVS Journal @ARVOiovs
5K Followers 577 Following Investigative Ophthalmology & Visual Science (IOVS) is an open access, peer-reviewed online journal of the Association for Research in Vision in Ophthalmology.
ICO @IntlCouncilOph
5K Followers 579 Following The International Council of Ophthalmology (ICO) works with ophthalmologic societies to improve eye care and restore vision for the people of the world.
Jing Liang 🇺🇦 @AppleHelix
8K Followers 4K Following Entrepreneur. Drug hunter. Novice biotech scripophile. Anti-ideologues. Proudly blocked by @VPrasadMDMPH. https://t.co/zMzJBoov2V
Elmo @BiotechElmo
4K Followers 359 Following Tweets are only opinion, speculation, and/or satire. Not investment advice or endorsement.
madaz @madaznfootballr
84K Followers 372 Following Full Time 8-Figure #Stonks Day Trader 🤑 w/13 Yrs Exp📈 #2 Ranked All Time Trader🏆(92.1% Career Win Rate) on @kinfo 📧:[email protected] IG:madazlifestyle
Jordan Alexander @JD4for4
7K Followers 298 Following LT investor looking for 5-10x upside over 3-5 years. Tweets are my own opinions & not investment advice.😘👰👦🧒👶
Joe Kunkle @OptionsHawk
102K Followers 839 Following Founder and CEO of OptionsHawk. Creator & Moderator of the Trading Hub, the Best Live Market Coverage **Not Investment Advice*** https://t.co/Qat4Ms2tCc
Dirk Haussecker @RNAiAnalyst
18K Followers 508 Following There are no alternative truths. Please do not allow evil to spread and destroy our freedom of life. Not investment advice
Jonathan Faison @jfais20
8K Followers 274 Following Founder of 500+ member ROTY Biotech Community. Focus on accelerating clinical & commercial momentum. Learning from my highs and lows, add value where I can
Vivi 👑 The Bio Que.. @Biotech_SD
40K Followers 2K Following My tweets are my opinions and not a financial advice ✈️🏂🏄 mom, options trader, patriot 🇺🇸 from 🇧🇷 in Cali living the dream #chartstraddlers #TraderVerse
happyycamperr @happyycamperr
2K Followers 3K Following Univ. of Penna.: BS-Economics; MBA Finance-Wharton||Ex Wall Street Analyst/Trader (Junk/Distressed, special situation). Prefer A to B and B to C but C to A.
Andrew Pannu @andrewpannu
10K Followers 274 Following daily dose of biotech & healthcare commentary • founder • building software for the bioeconomy (we’re hiring software engineers!)
Nick zheng @pick1998_2
6K Followers 485 Following Biotech stock trading and investing for 35 years. PhD in biology, MS in computer science.
BiopharmIQ by Amp @BiopharmIQ
21K Followers 348 Following Catalyst Calendar, Big Mover stocks & model portfolios. Database & tools to help with your biotech investing. not invstmnt advice. https://t.co/5njnanr11i #biotech
Matthew Gamber @MattBiotech
4K Followers 201 Following New writing out on April 30, 2024. Sign up at link at bio.
AF Biotech @AF_biotech
10K Followers 900 Following
Biotech Jim @JamesEKrause
11K Followers 548 Following phd biochem, not ichthyol; prof neurobiol, biotech entrepreneur, neurogeek, inventor, environmentalist focused on sustainability, also ERoEI. #neurosteroids
Persimmon Tree Invest.. @PersimmonTI
8K Followers 182 Following “The fault, dear Brutus, lies not within the stars, but in ourselves, that we are underlings.”Hope everyone is reading my lil’ ol’ free newsletter. From February 1:
A new study finds that outer retinal corrugations can be a clinical and diagnostic feature of Late-onset #retinal degeneration (L-ORD) on #OCT. Read more here: bit.ly/3v7ahmO #retina #ophthalmology #vision #eyes #genetics #imaging #health
Last chance to to submit your speaker applications for the 2024 #NORDSummit! Apply today to speak on topics including #DrugDevelopment, Accelerating Diagnosis, #HealthEquity, and more at this gathering of hundreds of #RareDisease leaders: bit.ly/3UKwMYO
Happy International Women's Day - throughout today we are featuring three remarkable females here at #UNSWSOVS. First up we have Dr Daisy Shu. Click on the link below to read more about Daisy's journey as an International Woman in Eye Research. bit.ly/48MY1Wj…
The 3rd Next Generation RNA Therapeutics Summit to be held in Boston, Mass. on May 7-9 2024 - please check the link for more information ow.ly/vK5r50QOxen #rarediseases #orphandrugs
Have your social media pledge cards ready? Downloadable in 8 languages from our website, show your support for Rare Disease Day now! Get them here: rarediseaseday.org/downloads/ #RareDiseaseDay #ShareYourColours #Awareness #LightUpForRare
Kiora’s Brian Strem shares early thoughts about retinal drug’s commercial positioning @KioraPharma Brian Strem shares early thoughts about the commercial positioning of lead asset KIO-301 w/ Jack O’Brien, plus policy updates & our Trends segment. mmm-online.com/home/podcasts/… #podcast
We are pleased to share an important update from @KioraPharma one of our @b2idigital featured companies. Kiora announced promising preliminary results from their Phase 1b ABACUS clinical trial evaluating KIO-301 for retinitis pigmentosa (RP). KIO-301 is an intravitreal molecular…
This October, join me in shining a light on the blind & visually impaired community during #BlindnessAwarenessMonth #thursdaymotivation #strongerbook #EyesOnYou #VisionaryAdvocates #EyeCareMatters #BlindnessAwareness #VisionMatters #drtasspeaks #positive365net
Navigating life as a legally #blind individual is made easier with the right resources. From understanding the definition to finding support groups and apps for #VisualImpairment, this guide has it all. t.ly/fcawQ #blindnessAwareness #EyeCare
October is World #Blindness Awareness Month! It was established for every October to help people understand the realities of living without sight. The WHO estimates that almost 285 million people suffer from blindness or visual impairment worldwide. #BeAware #EyeHealth
Opening our eyes to a world of understanding and support during Blindness Awareness Month. Together, we can make a difference. 👁️💙 #BlindnessAwareness #SeeWithYourHeart #cityofmiami
Over 50 attendees participated in the Western US Regional Meeting Saturday in Salt Lake City. A great day of education, community building and hope!
#RetinaAustralia has launched a new Register of #InheritedRetinalDisease Research Projects & Clinical Trials to provide information about research and trials that are being conducted around the world Find out if you can get involved here: retinaaustralia.com.au/information/re… #WorldRetinaDay
We're excited to welcome Kiora Pharmaceuticals, Inc. @KioraPharma (NASDAQ: $KPRX) to the @b2idigital family of Featured Companies. Please see their comprehensive B2i profile at b2idigital.com/kiora-pharma Visit Kiora's Investor Relations website at ir.kiorapharma.com Kiora…
This week's #BioTuesdays feature article - @KioraPharma (NASDAQ:KPRX) eyes novel approach to vision restoration in retinitis pigmentosa biotuesdays.com/2022/09/27/kio…
In the first episode of Adapt-Ability, Yvonne Shortt brings her experiences on the blindness spectrum to life with gusto and a refreshing outlook. It takes extraordinary courage to put one’s story on display so that we can all learn. Thank you, Yvonne. nytimes.com/2022/08/16/opi…
Meet Yvonne Shortt, who is legally blind. She lives a nuanced existence between those who see well and those who can't see a thing. “I could close my eyes, and I could still feel the snow,” she says in this Opinion video. nyti.ms/3zWC7R3
In this week's #EyeOnTheCurePodcast episode, host Ben chats with Brian Strem, PhD, CEO of @KioraPharma, about his company's emerging gene-agnostic small molecule for restoring vision for advanced #RP and potentially other retinal diseases. fightingblindness.org/news/eyecurepo…
.@KioraPharma has received authorization to launch a #ClinicalTrial for KIO-301, its emerging small-molecule therapy to restore vision in people with advanced retinitis pigmentosa (#RP) and potentially other retinal conditions. fightingblindness.org/research/kiora…
Trends for United States
You might like
